Tuesday, April 23, 2024

ULTRACON 2024- TOP TURNOUT FOR ULTRASOUND INDUSTRY CONFERENCE

For Immediate Release:

DR. ROBERT BARD & ULTRACON 2024: NY RADIOLOGIST DELIVERS RESOUNDING LECTURES ON IMAGING OF INFLAMMATORY DISORDERS TO THE INTERNATIONAL ULTRASOUND STAGE


AUSTIN, TX – April [23], 2024 – UltraCon2024, the ultrasound medicine industry conference hosted by the American Institute of Ultrasound in Medicine (AIUM) in Austin, TX, earlier this month, brought together the who's who in ultrasound medicine technology for a 3‐day event. More than a conference, UltraCon is billed as a "pivotal forum for debate, discovery, and dialogue,” and this year’s event certainly delivered. 

A defining characteristic of UltraCon is the convening of the brightest minds from around the globe who are actively shaping the future of ultrasound medicine. Speakers covered a wide array of topics, from feature‐based reports like the latest uses of 3D Doppler and Elastography, to “tips and tricks” to the complexity of organ‐based scan reviews. 

One such luminary is New York City-based cancer radiologist and internationally published ultrasound researcher Dr. Robert Bard. Elected in 2022 to a 6‐year term on the AIUM Therapeutic Ultrasound Community and became an AIUM fellow in 2022, Dr. Bard was honored to join many of the imaging community's top brands, innovators, and key clinical pioneers in Austin. 


Throughout the week in Austin, Dr. Bard delivered several in‐depth educational presentations on a number of topics, such as "Prostate Elastography," "Microvascular Image Guided Treatment of Arthritis," and an exploratory review of Ultrasound Validation of Pulsed Electromagnetic therapies. 

"It was such a great honor to finally attend one of the largest annual congregations of the finest leaders in imaging science,” said Dr. Bard. “It was invigorating to experience many of their educational presentations in reflection of the continued growth of the ultrasound imaging industry.” 

Dr. Bard also presented his latest research and expanded findings on the power of ultrasound technology on the diagnostics of chronic diseases and musculoskeletal disorders, and as a procedural supporter of image-guided treatments.

"Seeing Dr. Bard deliver his life's work on stage was witnessing legacy in action," says Dr. Lennard Goetze, Executive Director of the Angio Institute. "As a pioneer in the forefront of innovation, he cemented his place in history as one of the influencers of ultrasound advancement and a driver of the next generation."

Click to visit our 2024 UltraCon photo showcase

The AIUM is a multidisciplinary organization established in 1952 designed to advance the art and science of ultrasound in medicine research through educational, scientific, literary, and professional activities. According to Therese Cooper, Director of Accreditation at the AIUM, over 100 master class programs were presented by leading speakers, offering some of the most insightful and expansive reports direct from the field. 

"UltraCon surpassed our expectations in fostering a dynamic exchange of knowledge and ideas within the ultrasound community," said Dr. Richard Hoppmann, President of the AIUM. "The success of this year's conference was due to the caliber of speakers, exhibitors, and attendees, and underscores the vibrant spirit of innovation that drives our field. We are immensely proud of the collaborative advancements discussed and the groundbreaking technologies unveiled here, all of which promise to enhance patient care and shape the future of medical ultrasound."

Over 875 professionals attended to share and exchange information about the latest advancements in noninvasive imaging and the continuance of sonographic science advancement. Another dimension to the programming of Ultracon includes non‐CME sessions, such as a professional video lesson by Dr. Roberta Kline. Dr. Kline’s digital lecture was on the Benefits of Gene Expression in Assessing the Efficacy of Bioenergetic Interventions. 

“This non‐imaging oriented topic was such a great complement to the entire program… it held the scientific spirit of integrative collaboration – the very spirit that supports clinical imaging in the diagnostic community,” stated UltraCon attendee Dr. Leslie Valle-Montoya.

Walking through the exhibitors’ hall, attendees directly connected with some of the top brands at the forefront of ultrasound innovations including SIEMENS, GE, MINDRAY, CANON, SAMSUNG, and FUJI to name a few. Each booth showcased their latest models and was primed and ready to introduce their unique approach to advancing the ultrasound movement. 

Dr. Bard continued, “This event was so impressively organized and I was very inspired to connect, network, and collaborate with the other attendees. The AIUM designed an event that truly empowered the expansion of the clinical community and the future of the ultrasound technology... the AIUM did it right!"

About the AIUM: The American Institute of Ultrasound in Medicine is a multidisciplinary medical association of more than 9,000 physicians, sonographers, scientists, students, and other healthcare professionals. Established in the early 1950s, the AIUM is dedicated to empowering and cultivating a global multidisciplinary community engaged in the use of medical ultrasound through raising awareness, education, sharing information, and research.





ULTRACON 2024- A POWERFUL INDUSTRY NETWORK
"UltraCon provided me the opportunity to converse with individuals at every stage of their career. I networked with individuals whom were just entering the ultrasound realm to renowned radiologists. This was very beneficial as an exhibitor, Probo Medical was able to showcase Probo 360; impeccable service, parts, new and refurbished system sales, and probe sales/repair. UltraCon allowed me to gain an understanding of what customers around the world need and providing solutions to each unique situation.  One case in particular warmed my heart, I had the honor to meet a Physician from Cincinnati Children’s Hospital who was searching for a rare pediatric neuro probe to send to a community clinic in Ethiopia. She had plans to meet with the physician from Ethiopia the weekend after the show, time was of the essence. Probo Medical successfully found this probe and it is currently being used to diagnose children across the world.  UltraCon is definitely an event I will attend again, for the connections and stories alone this event is a must. I hope to see everyone in Florida next year!" - 
​Keith Gallagher / 
Senior Territory Manager , Probo Medical


Friday, June 23, 2023

Non-Invasive BioEnergy Pain Therapies - News feat. w/ Dr. Bard(CH11-WPIX)- by: Marvin Scott

 Original source: https://pix11.com/news/local-news/manhattan/cutting-edge-therapy-for-arthritis-and-other-chronic-pain/


(For faster access to video)
6/22/2023- Dr. Robert Bard @ Bard Diagnostics in NYC is featured in this special report about the latest innovations in non-invasive therapies for pain and inflammation.  This includes the expansion of Bioenergy Therapies like PEMF (Pulsed Electromagnetic Field) and Photobiomodulation (Near Infrared) devices to offer cell regenerative solutions to address a wide set of inflammatory disorders.
As a seasoned radiologist, Dr. Bard recognizes the demand for non-invasive solutions in the medical field.   Dr. Bard is also introducing the latest advancements in ultrasound and elastographic scanning as part of his "Scan and Treat" protocol for real-time efficacy tracking. 

This special report was brought to us by legendary journalist for CH11 news Mr. Marvin Scott, senior correspondent for WPIX-TV.   Mr. Scott has served in multiple capacities: as an anchor, reporter, host and producer. Mr. Scott is a member of the NYS Broadcasters Hall of Fame and recipient of 12 prestigious Emmy awards for journalistic achievement.




Advancements in ENERGY MEDICINE - By: Dr. Roberta Kline
The term "energy medicine" has been in general use since the founding of the International Society for the Study of Subtle Energies and Energy Medicine in the 1980s. Energy medicine often proposes that imbalances in the body's "energy field" result in illness, and that by re-balancing the body's energy-field health can be restored. Some modalities are described to "bring balance to the body's overall wellness", while others bring claims of addressing pain, detoxing, cell regeneration or improve overall energy. Every living thing requires energy to exist and function, and this comes in different forms. For example, in the human body are “energy generators” called the mitochondria. These tiny powerhouses in our cells convert fat, protein and glucose into ATP – the energy that fuels everything that is needed for us to be alive. When that vibrational frequency or information flow is disrupted or altered, cellular health suffers and the end result can range from minor aches and pains to major illness. But now our knowledge of the Energy of the Biofield also provides the opportunity for healing in a much more effective way that can complement or even replace the need for more invasive conventional therapies. (see complete report on Energy Medicine)


QUANTITATIVE IMAGING CONFIRMS THERAPEUTIC RESPONSE  - By: Dr. Robert Bard
One of the most comprehensive ways to confirm the results of any treatment is by clinically tracking the body's physiological response from underneath the skin. Diagnostic imaging captures measurable data about the injured or inflamed area, allowing both clinicians and patients the ability to identify therapeutic progress in real time. Widely preferred scanning modalities include the Doppler Blood Flow Ultrasound (or sonography) and Elastography, both using high-frequency sound waves to view inside the body. Like an internal video camera, these high speed scanning innovations capture actual movement of the body's internal organs. This offers a vast amount of biometric information about the patient’s condition, in comparison to still images of conventional x-rays. The ultrasound's ability to evaluate abnormalities within the soft tissue in research and clinical trials are widely used in recording evidence-based biomarkers to trace therapeutic efficacy.


INFLAMMATION 101: by: Josh Schueller, PT
Part of the complex biological response of body tissues to harmful stimuli (such as pathogens, damaged cells, or irritants) is inflammation. It is also a protective response involving immune cells, blood vessels, and molecular mediators. The function of inflammation is to eliminate the initial cause of cell injury, clear out necrotic cells and tissues damaged from the original insult and the inflammatory process, and initiate tissue repair.

The five cardinal signs are heat, pain, redness, swelling, and loss of function. Inflammation is a generic response, and therefore it is considered as a mechanism of innate immunity. Too little inflammation could lead to progressive tissue destruction by the harmful stimulus (e.g. bacteria) and compromise the survival of the organism. In contrast, too much inflammation, in the form of chronic inflammation, is associated with various diseases, such as hay fever, periodontal disease, atherosclerosis, and osteoarthritis. ACUTE inflammation is the initial response of the body to harmful stimuli from the blood into the injured tissues. A series of biochemical events propagates and matures the inflammatory response within the injured tissue. Prolonged or CHRONIC inflammation, leads to a progressive shift in the type of cells in the inflamed area and is characterized by simultaneous destruction & healing of the tissue from the inflammatory process.


PHOTOBIOMODULATION
Low-level laser therapy (LLLT) or photobiomodulation (PBM) is a form of medicine that applies low-power lasers or light-emitting diodes (LEDs) to the surface of the body. It is claimed that application of low-power lasers relieves pain or stimulates and enhances cell function. It addresses the underlying cause of all dysfunction in the body (inflammation & disease) and that is cellular health and wellness. Red light is known for its ability to penetrate deeper into the skin- and can be absorbed by cells deep in the body. Today's technology offers Red Light therapy in a variety of devices with different capacities, including the red light bed panels and targeted deep tissue laser therapy systems.


ELECTROMAGNETICS
PEMF (pulsed electromagnetic fields) devices have a wide range of frequencies available. They can influence cell membrane potentials of many different tissues to enhance communication and increase blood flow, decrease inflammation and activate a number of genes possibly through epigenetics. Pharmacology is also leveraging electromagnetics to explore more effective ways of getting medications into cells. Drug delivery systems are being developed using nanoparticles that can manipulate cell membrane electromagnetic fields to improve absorption. In 1979 the FDA approved PEMF therapy for stimulating bone growth, and in 1987 for adjunct therapy for treating postoperative edema and pain. The FDA also approved PEMF therapy for the treatment of patients with depression in 2011. For both animals and humans, PEMF therapy is marketed commercially to address inflammation by stimulating microcirulation, the lymphatic vessels and mobilizing toxins from the cells more efficiently. PEMF therapy is also reported to support restorative health mechanically by improving blood flow.

This educational literature is brought to you by the educational dept. of: BARD DIAGNOSTIC IMAGING

ch11

Non-Invasive BioEnergy Pain Therapies - News feat. w/ Dr. Bard(CH11-WPIX)- by: Marvin Scott


6/22/2023- Dr. Robert Bard @ Bard Diagnostics in NYC is featured in this special report about the latest innovations in non-invasive therapies for pain and inflammation.  This includes the expansion of Bioenergy Therapies like PEMF (Pulsed Electromagnetic Field) and Photobiomodulation (Near Infrared) devices to offer cell regenerative solutions to address a wide set of inflammatory disorders.
As a seasoned radiologist, Dr. Bard recognizes the demand for non-invasive solutions in the medical field.   Dr. Bard is also introducing the latest advancements in ultrasound and elastographic scanning as part of his "Scan and Treat" protocol for real-time efficacy tracking. 

This special report was brought to us by legendary journalist for CH11 news Mr. Marvin Scott, senior correspondent for WPIX-TV.   Mr. Scott has served in multiple capacities: as an anchor, reporter, host and producer. Mr. Scott is a member of the NYS Broadcasters Hall of Fame and recipient of 12 prestigious Emmy awards for journalistic achievement.




Advancements in ENERGY MEDICINE - By: Dr. Roberta Kline
The term "energy medicine" has been in general use since the founding of the International Society for the Study of Subtle Energies and Energy Medicine in the 1980s. Energy medicine often proposes that imbalances in the body's "energy field" result in illness, and that by re-balancing the body's energy-field health can be restored. Some modalities are described to "bring balance to the body's overall wellness", while others bring claims of addressing pain, detoxing, cell regeneration or improve overall energy. Every living thing requires energy to exist and function, and this comes in different forms. For example, in the human body are “energy generators” called the mitochondria. These tiny powerhouses in our cells convert fat, protein and glucose into ATP – the energy that fuels everything that is needed for us to be alive. When that vibrational frequency or information flow is disrupted or altered, cellular health suffers and the end result can range from minor aches and pains to major illness. But now our knowledge of the Energy of the Biofield also provides the opportunity for healing in a much more effective way that can complement or even replace the need for more invasive conventional therapies. (see complete report on Energy Medicine)


QUANTITATIVE IMAGING CONFIRMS THERAPEUTIC RESPONSE  - By: Dr. Robert Bard
One of the most comprehensive ways to confirm the results of any treatment is by clinically tracking the body's physiological response from underneath the skin. Diagnostic imaging captures measurable data about the injured or inflamed area, allowing both clinicians and patients the ability to identify therapeutic progress in real time. Widely preferred scanning modalities include the Doppler Blood Flow Ultrasound (or sonography) and Elastography, both using high-frequency sound waves to view inside the body. Like an internal video camera, these high speed scanning innovations capture actual movement of the body's internal organs. This offers a vast amount of biometric information about the patient’s condition, in comparison to still images of conventional x-rays. The ultrasound's ability to evaluate abnormalities within the soft tissue in research and clinical trials are widely used in recording evidence-based biomarkers to trace therapeutic efficacy.


INFLAMMATION 101: by: Josh Schueller, PT
Part of the complex biological response of body tissues to harmful stimuli (such as pathogens, damaged cells, or irritants) is inflammation. It is also a protective response involving immune cells, blood vessels, and molecular mediators. The function of inflammation is to eliminate the initial cause of cell injury, clear out necrotic cells and tissues damaged from the original insult and the inflammatory process, and initiate tissue repair.

The five cardinal signs are heat, pain, redness, swelling, and loss of function. Inflammation is a generic response, and therefore it is considered as a mechanism of innate immunity. Too little inflammation could lead to progressive tissue destruction by the harmful stimulus (e.g. bacteria) and compromise the survival of the organism. In contrast, too much inflammation, in the form of chronic inflammation, is associated with various diseases, such as hay fever, periodontal disease, atherosclerosis, and osteoarthritis. ACUTE inflammation is the initial response of the body to harmful stimuli from the blood into the injured tissues. A series of biochemical events propagates and matures the inflammatory response within the injured tissue. Prolonged or CHRONIC inflammation, leads to a progressive shift in the type of cells in the inflamed area and is characterized by simultaneous destruction & healing of the tissue from the inflammatory process.


PHOTOBIOMODULATION
Low-level laser therapy (LLLT) or photobiomodulation (PBM) is a form of medicine that applies low-power lasers or light-emitting diodes (LEDs) to the surface of the body. It is claimed that application of low-power lasers relieves pain or stimulates and enhances cell function. It addresses the underlying cause of all dysfunction in the body (inflammation & disease) and that is cellular health and wellness. Red light is known for its ability to penetrate deeper into the skin- and can be absorbed by cells deep in the body. Today's technology offers Red Light therapy in a variety of devices with different capacities, including the red light bed panels and targeted deep tissue laser therapy systems.


ELECTROMAGNETICS
PEMF (pulsed electromagnetic fields) devices have a wide range of frequencies available. They can influence cell membrane potentials of many different tissues to enhance communication and increase blood flow, decrease inflammation and activate a number of genes possibly through epigenetics. Pharmacology is also leveraging electromagnetics to explore more effective ways of getting medications into cells. Drug delivery systems are being developed using nanoparticles that can manipulate cell membrane electromagnetic fields to improve absorption. In 1979 the FDA approved PEMF therapy for stimulating bone growth, and in 1987 for adjunct therapy for treating postoperative edema and pain. The FDA also approved PEMF therapy for the treatment of patients with depression in 2011. For both animals and humans, PEMF therapy is marketed commercially to address inflammation by stimulating microcirulation, the lymphatic vessels and mobilizing toxins from the cells more efficiently. PEMF therapy is also reported to support restorative health mechanically by improving blood flow.

This educational literature is brought to you by the educational dept. of: BARD DIAGNOSTIC IMAGING

Thursday, February 2, 2023

MOLE REMOVAL LEAVING NO SCAR!


As an industry expert, Ms. Howard has unique access to just about any aesthetic technology.  She elected to pursue the mole removal through the use of PLASMA FIBROBLAST due to her confident belief in its ability to safely remove skin growths while managing the remaining skin to not leave any scars.  "My mole rested in a tricky/sensitive area (sternum) where excisions have a greater risk of leaving scar. While older methods like freezing or cutting it would most likely have left to scar, I learned about the science of the Plasma Fibroblast technique and was convinced that this was the way to go."

Upon deeper review on her entire journey, Ms. Howard explains that her provider performed a special technique with the 'plasma pen' to extract the tissue mass and also 'build up' the skin around the mole area so it would heal flat- and not leave a concave situation that most mole removals tend to leave behind.

"I have been hesitating to get rid of this mole for many years because every doctor I spoke to talked me out of it... and was firm on the fact that there was no way for this to be removed without a gnarly scar.  Then one day, I met with Mario Barton (CEO of Nuvissa) and Rachel Levy (trainer)- who both gave me tremendous education in the technology.  This all gave me peace of mind alongside the promise that the aftermath was going to be absolutely favorable.  Sure enough, weeks later (see image enclosed), the plasma fibroblast did not disappoint. No scar!"




DIAGNOSTIC IMAGING UNDER THE SKIN

10/21/2022- Ms. January Howard (Ft. Lauderdale, Fla), national expert trainer in minimally invasive facial enhancement procedures (Chemical Peels, PRP, Micro-needling, Biologic fillers) meets renowned medical diagnostic imaging specialist Dr. Robert L. Bard in his NYC office to discuss a collaborative educational program about image guided procedures for medispas and aesthetics professionals.  During this meeting of the minds, they confirmed the need for pre and post-op monitoring and the power of ultrasound technology as the future of safety techniques for the growing list of clinical aesthetic enhancement protocols.

Scanning a mole with the Doppler ultrasound

Deeper insight came to light about the technology arose from a real-time diagnostic scenario when Dr. Bard was conducting a standard demo of his scanning equipment directly on Ms. Howard.  Dr. Bard noticed a curious raised 7mm mole on her sternum and offered to screen it- partly for her peace of mind. “I have been concerned about that mole for years alongside 30 others all over my body”, stated Ms. Howard. “To be at the right place with Dr. Bard (a cancer imaging expert) is such a blessing… he toured me through what’s under and on my skin in a way that no clinician had ever done before. His real-time scanning and his extensive knowledge in reading anomalies is truly a gift to the aesthetics community!”

Thanks to the 3D Doppler (blood flow) scan of the mole, Ms. Howard was relieved to receive an official medical report that this growth was indeed benign, and ready for a future excision. Dr. Bard’s assessment was just one example of the diagnostic power of real-time scanning—a vital resource for any aesthetician working on or under the skin.  “To identify potential land mines for occlusion offers a major advantage in ‘lawsuit prevention’ for any practitioner… with today’s high powered probes and functionalities like elastography and blood flow readings, gathering biometric data is made readily available for just about any budget.”

January Howard is the CEO of MedSpa 101 (medspa101.com), an aesthetic practice consultancy group and expert trainer in specialized clinical modalities.  She is a chapter co-author in Dr. Bard’s upcoming Springer textbook “INDUSTRY REVIEW OF THE AESTHETIC INDUSTRY” along with some of the top names in the aesthetics community- to launch this spring of 2023.  Additional information on this textbook is available at: www.dermalscannyc.com





TRAUMA AND TOXINS: Non invasive diagnostics
Written by: Robert Bard MD

The human body is continually assaulted by harmful forces which may be obvious (trauma and burns) or subtle and dismissed as the “flu or nerves” (chronic poisoning and delayed hidden scarring). However, in the unregulated world of fillers, patients and physicians often discover unexpected findings (forgotten surgical sutures) and complication as potential medicolegal traps. One picture is worth a thousand words and one image may launch a thousand lawsuits while possibly giving birth to a new medical image guided treatment paradigm. 

TRAUMA
Soft tissue trauma causes a black and blue area but subcutaneous pathology is best imaged by ultrasound. The normal dermal layer is light gray on scans while inflammation is dark gray and fluid (blood) is black. Dermal ultrasound has been used for 30+ years to find skin cancer and guide scar treatment so the use in subacute trauma victims is a logical progression of this portable and non invasive technology. Foreign bodies such as glass and splinters are easily visible as bright white reflectors that directs the surgeon to the exact removal site under ultrasound guidance with minimal tissue “exploration” Fillers have characteristic echo pattern where HA products appear as black globules when they coalesce.  Often the HA injected aliquot disperses immediately leaving a diffuse hazy picture. Complications of fillers are well described in recent textbooks. A special case is free silicone having specific “snowstorm” pattern that is commonly seen in breast imaging of ruptured implants. The theoretical possibility of immune system compromise by free silicone is still being studied.

FIBROTIC SCARRING
Elastography shows scar tissue quantitatively in the liver parenchyma but also in traumatized muscles and tendons. The “elastic” properties of tissue are used worldwide for cancer diagnostics because malignant tumors are rock hard and “gritty” with the needle biopsy while benign lumps are soft. Ultrasound maps tissue signatures of free silicone has a mean gray (MG) value 35-40 on a black to white scale.

SKIN OF COLOR
The headline from the 2022 fall issue of PSORIASIS ADVANCES noted inflammatory disease is often misdiagnosed in skin of color. Bruises, burns and infections are detected by color-blind ultrasound as dark areas in the light gray tissues often highlighted by a “ring of fire” blood flow reaction to the local tissue reaction 




(Fig 1-L) 45 year female with collagen disease chief complaint of  fullness post filler. Sonogram at 18MHx shows a 0.2mm epidermis which expands to 9mm over the tender area. Black HA filler caps the 16x16mm light grey focus of free silicone. Under ultrasound guidance the needle depth was recalculated to avoid injecting and possibly dispersing the silicone material.







REFERENCES
2014 Bard/Marmur Mt Sinai Clinical Trial on Hyaluronidase Efficacy  
2020 Bard R: Image Guided Management of Covid Lung Disease  2020 SpringerBerlin
2021 WTC Occupational Cancer Registry: Statistics from Ground Zero 2001
2021 International Inflammatory Disease Symposium  NY Academy of Medicine
2022 National Psoriasis Foundation 20:31 NPF Advances
2023 Bard R: Proceedings; Therapeutic Ultrasound Committee of American Institute of Ultrasound in Medicine






REFLECTANCE CONFOCAL MICROSCOPY-
THE LATEST IMAGING ADVANCEMENT FOR DERMATOLOGISTS

Feature updated from original publishing (8/19/2019)- The modern era of diagnostic clinical imaging continues to expand in areas of optimal speed, sensitivity and feasibility as part of its continued pursuits to bring a non-invasive diagnostic modalities to our treatment community. The Reflectance Confocal Microscopy (RCM) gives dermatologists a major upgrade (over age-old microscopy) in their ability to assess pathologic and physiologic conditions of the skin with a higher level of clinical accuracy, greatly supporting the reduction of calls for biopsies of benign lesions. Responding to the limitations of biopsies and conventional screening methods, the non-invasive movement brings a heightened level of performance and responsiveness in areas of resolution, magnification, depth, contrast, and immediate results from bedside. Please see Dr. Manu Jain's complete technology tour @ Modern Diagnostic Science

Wound Healing in Skin of Color

Written by: Mary Nielsen, Robert Bard, MD & Paul Dreschnack, MD / A report from DermalScanNYC.com

People with skin of color share some dermal characteristics, including a greater potential to develop post inflammatory hyperpigmentation, and keloid and/or hypertrophic scarring. Additionally erythema can be masked in darker skin tones because of the background pigmentation. Inflammatory changes in the skin can manifest as purple, grey or various shades of brown, rather than red. Relying on erythema as a sign of inflammation in skin of color may result in delayed diagnoses or misdiagnoses because most descriptions and photos of dermatological skin conditions are taught in the context of white skin.

Post-inflammatory hyperpigmentation (PIH) happens when there is injury, friction, irritation or heat applied to the skin, wounding the skin. The active melanocytes in skin of color react in an effort to protect the skin from further damage. The skin may turn tan, brown, or even a purple color. Over 65% of Americans of African descent experience symptoms of PIH.

PIH can be epidermal, involving the top layer of skin or dermal, in the deeper layers of the dermis or mixed. The type of PIH can be determined through special lighting using a digital system. Post inflammatory hyperpigmentation can take months and even years to clear. Often aggressive therapy to treat the PIH can risk the worsening of pigmentation as the melanocytes work to protect the skin.

Keloids are a type of raised scar that occurs on the skin after wounding. The healing process appears to be complete because the epidermis is intact. The reticular dermis is still in a state of inflammation, with fibroblast activity producing an over abundance of collagen. Keloids can develop due to wounding from piercings, cuts, tattoos, insect bites, puncture wounds, post- surgical scars, shaving cuts and even micro-injuries from tightly braided hair.

Keloids are more common in people of color, especially Asian, Latinx and African descent.

Keloids can appear three to twelve months after the wounding of the skin. The scar will eventually turn darker than the person’s skin, although initially it will be pink, red or purple. The borders are often darker than the center. Most keloids grow slowly over a period of weeks or months although some grow more rapidly. While they are growing keloids may feel tender and itchy. The sensations stop once the keloid stops growing. Most are solid and stable.

Wearing a pressure garment over a wounded area, including a pressure earring after a piercing may help prevent keloid growth.

Surgeons can take some proactive measures to help prevent keloid formation due to a surgical wounding of the skin. To close an incision, stitches should be placed in the subcutaneous and deep dermis. Dissolvable stitches that create tension-free closures are preferred. The use of special scar creams or silicone adhesives have been proven to improve the quality of the scar.

DERMAL TRANSILLUMNATION
Since 1906 light transmission in breast tissue has been useful in detecting deoxyhemoglobin which is produced by cancerous tissue and trauma. Light absorption quantification is particularly useful in evaluation of dermal and subdermal hemorrhage since it is more sensitive than the spatially limited human eye. Illumination has the advantage of a “no contact” technology and is being emulated by remote ultrasound analysis of reflected and refracted optical sources for future diagnostic uses.

DERMAL ELASTOGRAPHY
Advances in the physical elasticity properties of tissue were first investigated by the Japanese in malignant melanoma and soft tissue sarcomas in 1990 since cancers are firm and benign lesions are soft and pliable. Strain elastogram verifiable results led to more accurate and quantifiable shear wave data that is replacing tissue biopsies in tumors of the Achilles tendon, breast, thyroid, liver, pancreas, testicle and prostate in many countries.    As tissue hardens in a hyperimmune fashion, steps to diminish hyper inflammatory such as electromagnetic fields and other mesotherapies may prove useful.                                                   

FUNCTIONAL TREATMENT BIOLOGY
Radiation produces free radicals that damage DNA as the electromagnetic energy disrupts mitosis in rapidly dividing cells.  While normal cells repair damage, treated cancer cells cannot divide and are considered inactive or sterilized. This means that cancer cells that grow slowly may die slowly and the surgical specimen looks microscopically like active cancer but is, in fact, physiologically inactive while appearing functional to the pathologist. Therefore a biopsy may be “positive” while the cancer is biologically dormant. Similarly, the size of a treated tumor poorly correlates with treatment success since edema from dying cells or infiltration with T cells and other immunologic tissues transiently enlarge the tumor mass while it has lost its metastatic potential. (12, 13, 14)

TREATMENT VERIFICATION
The overall recurrence rate of disease is measurable by Doppler blood flow imaging and by quantitative shear wave elastographic changes and is being used as a bloodless biopsy in inflammatory disease therapeutic algorithms.

MICROVASCULAR PHYSIOLOGY
The smooth muscle content of vascular structures responds to the hormonal and autonomic nervous system control and is sensitive to electromagnetic fields (EMF) Blood flow measurable in the microvessels by Doppler ultrasound, speckle laser photometry, optical coherence tomography, intravital microscopy, dual photon-spectroscopy and reflective confocal microscopy may be studied non invasively in real time providing assessment of treatment effect and correlated with metabolic testing and functional genomics.

Blood distribution control mechanisms in the pre and post capillary microcirculation depends on the vessel caliber have 3-5 vasomotions/minute whereas larger vessels upstream and downstream have 1 vasomotion/minute. The faster vasomotion of the smallest vessels takes place autorhythmically while the larger vessels are controlled by the hormonal and/or autonomic nervous system. Aging effect and disease status reduces the frequency on vasomotion while certain signal configurations carried on the electromagnetic wave increase the vasomotion thereby increasing blood flow, tissue oxygenation, venous return and glymphatic clearance of waste products supporting tissue regeneration and immunologic activity.  Worldwide this non invasive technology is successfully used for diabetic disease of the eye and foot, inflammatory skin disease and has been FDA approved for fracture healing over 30 years ago.


INFLAMMATORY DERMATITIS / INTESTINAL INFLAMMATION
Generally considered autoimmune diseases, electromagnetic therapy increases venous flow out of the microvascular networks, extends the plasma distribution in the capillary network and increases spontaneous arteriolar vasomotion resulting in better regional oxygenation. Parallel changes of the subcutaneous tissue and intestine occur with functional electromagnetic treatment [1] The use for psoriasis began about 40 years ago in Italy [2] The immune system response to tissue injury involves homeostasis and cell signaling that affects the rate of healing and scarring as stem cells are important in tissue regeneration [3].  Low frequency EMF induces changes in cell proliferation, membrane structure and function, protein phosphorylation and adenosine triphosphate [ATP] synthesis [4] Successful regeneration requires an immune response that accurately polarizes immune cells so they balance between proinflammatory and pro-regenerative cell types. When inflammation becomes chronic multipotent mesenchymal stem cells [MSCs] modulate the recovery process [5] Healing involves cellular debris removal, activation of progenitor cells, immune modulation, angiogenesis and innervation  of the regenerating tissue [6] Electromagnetic induction dosimetry incudes frequency, intensity and duration/time of exposure to balance the pro and anti-inflammatory signaling processes of IL-1 beta secretion important in type 2 diabetes and other inflammatory states [7] EMF acts on Calcium concentrations and Na/K pathways in humans [8] and modulates endogenous electrical potential in plants, animals and humans [9]  Continuous anecdotal reporting of the salutary effects of EMF are likely due to the cellular effect on homeostatic mechanisms [10] and improvement in gut health seems due to decreased sticking of red blood cells and increased flow of white blood cells to penetrate into smaller capillaries

 

 Potential clinical studies from this stacking of diagnostic with therapeutic systems include:

1-skin thickness; epidermis and dermis with elastographic data on specific sites  a-glabrous skin vs non glabrous area; b-facial regions from eyelid, ear, nose, glabella including muscle thickness with 7 Tesla MRI correlation

2-nail thickness and elastogram hands/feet

3-treatment verification using laser speckle Doppler/OCT/RCM of elastographic changes during therapy in real time

4-analysis of skin of color: epidermis, intradermal layers with elastographic correlation

5-analysis of diabetic skin changes with elastography and blood flow

6-analysis of dense breast tissue with elastographic correlation

7-demonstrating abnormal systolic resistive indices as a surrogate marker to initiate reduced inflammatory response with PIH and keloid formation

 

REFERENCES

1-Mikrozirculation im Focus der Forschung  ISBN 978-3-033-01464-0; 421-424, 2008

2-Castelpietra R etal [Initial experiences in the treatment of psoriasis with pulsating magnetic fields] Minerva Med 75: 2381-2387, 1984

3-Ross CL etal  The use of Pulsed Electromagnetic Field to Modulate Inflammation and Improve Tissue Regeneration Bioelectricity 1:247-259, 201R9

4-Bassett C  Fundamental aspects of therapeutic uses of pulsed electromagnetic fields [PEMF] Crit Rev Biomed Eng 17:451-529, 1989

 

 

Copyright© 2023- Bard Publishing/Angiofoundation Press. All rights reserved.


Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers of the AngioFoundation/AngioPublishing (501c3). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

 

 

 

 

 

 

 

Thursday, January 19, 2023

DENSE BREAST NEWS: 2023

1/19-2023- The ARE YOU DENSE ADVOCACY committee continues to recognize the importance of patients receiving their own personal medical information and directs the Food and Drug Administration to ensure that mammography reports and summaries received by patients and their providers include appropriate information about breast density specified by the Secretary, including, at a minimum, the effect of breast density in masking the presence of breast cancer on a mammogram, the qualitative assessment of the provider who interpreted the mammogram, and a reminder to patients that individuals with dense breast tissue should talk with their providers if they have any questions or concerns about their summary. From a prior report (3/28/2019) the Department of Health and Human Services, the FDA announced changes to the MQSA (Mammography Quality Standards Act) to include reporting of dense breast tissue to the patient- by and large, thanks to the Are You Dense Advocacy, Inc. Today,  [1]


Joe Cappello / Are You Dense? Foundation
According to a 12/13/2022 press release,  Congresswoman Rosa DeLauro (CT-03), Congressman Brian Fitzpatrick (PA-01), and award-winning journalist Katie Couric introduced their legislation, the Find It Early Act. This bill would ensure all health insurance plans cover screening and diagnostic mammograms and breast ultrasounds and MRIs with no cost-sharing.  “It means a great deal to me to join Katie Couric, Congressman Fitzpatrick, and all of the breast cancer advocates here to talk about what we must do to detect breast cancer early and save women’s lives,” said Congresswoman Rosa DeLauro. “As we all know, when it comes to surviving cancer, early detection is key – as 99 percent of women who receive an early diagnosis survive it. That is why today I am introducing the Find It Early Act, which would mandate all insurance providers to cover additional screenings including diagnostic mammograms, breast ultrasounds, and breast MRIs, with no cost-sharing.” “At DenseBreast-info we hear from women all the time who find out they have dense breasts and that they would benefit from additional screening, but then discover they have to navigate getting approvals from their insurance providers - and begina frustrating cycle of phone calls, denials, appeals and more phone calls,” said JoAnn Pushkin, Executive Director of DenseBreast-info, Inc. “The Find it Early Act will help ensure that when a woman is told that her mammogram might not be enough – she will not have to struggle to pay for additional imaging, orchoose between household bills and a recommended test, or spread the cost of an MRI over one year, and skip the next year because the cost of the exam has strained her budget.”
“It is my pleasure to give a voice on behalf of many hundreds of dense breast cancer patients who have become advocates across this country to say THANK YOU Congresswoman DeLauro,” said Joseph J. Cappello, Executive Director and Co-Founder of Are You Dense Advocacy, Inc. “We thank you for taking the initiative as a leader in our 18-year battle, by demanding the FDA take action on the new MQSA rule by the end of this month. Your leadership will save many hundreds of lives across the nation.” [4]

Video News Release: Innovations in Early Detection

"Are You Dense?" Foundation Co-founder Joe Cappello joins the medical diagnostic community to promote the "Get Checked Now!" campaign. Dr. Robert Bard from the Bard Cancer Center (NYC) supports supplemental imaging including the 3D Doppler Ultrasound scanner to offer dense breast detection.  This video presents some of the latest advancements in ultrasound features to detect tumors through dense breast tissue- reportedly a significant challenge with mammograms. 

WHAT'S NEW AT THE MQSA (NATIONAL STATISTICS)

Welcome to MQSA Insights. These pages provide information pertaining to the Food and Drug Administration’s (FDA) Mammography Quality Standards Act’s (MQSA) program. Our ultimate goal is to help facilities improve the quality of mammography by allowing them to see how facilities as an aggregate are doing across the nation as well as through exploring specific mammography topics. Such information is designed to:

  • inform the public on how mammography facilities are doing overall complying with MQSA standards
  • highlight other important MQSA statistics and trends
  • allow facilities to compare how they are performing to the performance of facilities as a whole [2]

SEE the latest MQSA Insights presenting the most commonly requested national statistics regarding the MQSA program. These statistics are updated on the first of each month. (LINK)







REPRISE: DR BARD IS CALLED AS MEDICAL EXPERT IN 'SPOTLIGHT ON AMERICA" FEATURE ON DENSE BREAST RESEARCH REPORT

Courtesy: "Are You Dense?" Foundation
Updated from a video feature originally launched on 10/14/2022, Spotlight on America (TND) presented an ongoing report: "A SHOCKING DIAGNOSIS". Suzanne McDonald was 48 years old when she got a routine mammogram in 2007. Like so many women, she received a letter telling her the X-ray was clear, and she breathed a sigh of relief. McDonald threw her letter in the garbage, trusting that it told her all she needed to know. She’d later find out that the mammogram had missed what was happening in her body: late-stage 3C cancer, which had been concealed by extremely dense breast tissue, which McDonald had never heard of.  

The image of a tumor in a dense breast (R) is like a polar bear in a snowstorm,” Dr. Robert Bard, a leading radiologist, told us. “It’s white against white, you can’t see it. So we’ve been missing tumors all the time.”   Bard, the founder of the Bard Cancer Center, told us the lack of contrast in those crucial images means millions of women could miss their best chance at early detection. “Women with dense breasts are 5 to 7 times more likely to develop a breast tumor,” said Dr. Bard. “So given that you’re already at increased risk by having a high breast density, this is cause for making sure you get screened.”

Special thanks to TND/ Andrea Nejman | National Investigative Producer & Spotlight on America, Inside Your World Investigates


HANDY PATIENT GUIDE TO SCREENING OPTIONS FOR DENSE BREASTS
This patient-friendly guide outlines the benefits and harms of screening options for dense breasts. The two-page guide is based on current scientific and medical research on technology and dense breast tissue. The guide illustrates the approximate cancer detection rate for each exam. Bring this guide with you as you discuss your screening options with your health-care providers based on your risk, dense tissue and preferences.  Keep in mind that all studies have limitations. The chart can be printed one page, back to back.  (Special thanks to Julie S. Gershon, MD for her expert review). Download Chart in PDF here. [3]

















RESOURCES

1) https://www.areyoudenseadvocacy.org/news/map-all-pink
2) https://www.fda.gov/radiation-emitting-products/mammography-quality-standards-act-and-program/mqsa-insights
3) https://www.areyoudenseadvocacy.org/resources/handy-patient-guide-screening-options-dense-breasts
4) https://delauro.house.gov/media-center/press-releases/delauro-fitzpatrick-katie-couric-introduce-find-it-early-act-2022



This feature article is brought to you in part by:




 

ULTRACON 2024- TOP TURNOUT FOR ULTRASOUND INDUSTRY CONFERENCE

For Immediate Release: DR. ROBERT BARD & ULTRACON 2024: NY RADIOLOGIST DELIVERS RESOUNDING LECTURES ON IMAGING OF INFLAMMATORY DISORDERS...